EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6889 - methylprednisolone acetate
| Formula | C24H32O6 |
| Net Charge | 0 |
| Average Mass | 416.514 |
| Monoisotopic Mass | 416.21989 |
| SMILES | [H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@@]21C |
| InChI | InChI=1S/C24H32O6/c1-13-9-16-17-6-8-24(29,20(28)12-30-14(2)25)23(17,4)11-19(27)21(16)22(3)7-5-15(26)10-18(13)22/h5,7,10,13,16-17,19,21,27,29H,6,8-9,11-12H2,1-4H3/t13-,16-,17-,19-,21+,22-,23-,24-/m0/s1 |
| InChIKey | PLBHSZGDDKCEHR-LFYFAGGJSA-N |
| Roles Classification |
|---|
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. hormone Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. anti-inflammatory drug A substance that reduces or suppresses inflammation. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. anti-inflammatory agent Any compound that has anti-inflammatory effects. anti-asthmatic agent Any compound that has anti-asthmatic effects. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. antirheumatic drug A drug used to treat rheumatoid arthritis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| methylprednisolone acetate (CHEBI:6889) has functional parent 6α-methylprednisolone (CHEBI:6888) |
| methylprednisolone acetate (CHEBI:6889) has role analgesic (CHEBI:35480) |
| methylprednisolone acetate (CHEBI:6889) has role anti-anaemic agent (CHEBI:75835) |
| methylprednisolone acetate (CHEBI:6889) has role anti-asthmatic agent (CHEBI:65023) |
| methylprednisolone acetate (CHEBI:6889) has role anti-inflammatory agent (CHEBI:67079) |
| methylprednisolone acetate (CHEBI:6889) has role anti-inflammatory drug (CHEBI:35472) |
| methylprednisolone acetate (CHEBI:6889) has role antineoplastic agent (CHEBI:35610) |
| methylprednisolone acetate (CHEBI:6889) has role antirheumatic drug (CHEBI:35842) |
| methylprednisolone acetate (CHEBI:6889) has role dermatologic drug (CHEBI:50177) |
| methylprednisolone acetate (CHEBI:6889) has role gout suppressant (CHEBI:35845) |
| methylprednisolone acetate (CHEBI:6889) has role ophthalmology drug (CHEBI:66981) |
| methylprednisolone acetate (CHEBI:6889) is a 11β-hydroxy steroid (CHEBI:35346) |
| methylprednisolone acetate (CHEBI:6889) is a 17α-hydroxy steroid (CHEBI:35342) |
| methylprednisolone acetate (CHEBI:6889) is a 20-oxo steroid (CHEBI:36885) |
| methylprednisolone acetate (CHEBI:6889) is a 3-oxo-Δ1,Δ4-steroid (CHEBI:77166) |
| methylprednisolone acetate (CHEBI:6889) is a acetate ester (CHEBI:47622) |
| methylprednisolone acetate (CHEBI:6889) is a glucocorticoid (CHEBI:24261) |
| methylprednisolone acetate (CHEBI:6889) is a steroid ester (CHEBI:47880) |
| methylprednisolone acetate (CHEBI:6889) is a tertiary α-hydroxy ketone (CHEBI:139592) |
| IUPAC Name |
|---|
| (6α,11β)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate |
| Synonyms | Source |
|---|---|
| 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate | KEGG COMPOUND |
| 6alpha-Methylprednisolone 21-acetate | KEGG COMPOUND |
| 6alpha-Methylprednisolone acetate | ChemIDplus |
| Depo-medrol | ChemIDplus |
| Depo-Methylprednisolone acetate | ChemIDplus |
| Methylprednisolone 21-acetate | ChemIDplus |
| Brand Names | Source |
|---|---|
| Depo-medrone | ChEMBL |
| Methylprednisolone acetate component of neo-medrol acetate | ChEMBL |
| Neo-medrone | ChEMBL |
| Citations |
|---|